Training for Academic Hematology
学术血液学培训
基本信息
- 批准号:6897797
- 负责人:
- 金额:$ 21.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
This application is for a new (type 1) PHS Institutional National Research
Service Award to prepare fellows for an academic career in Hematology at the
University of California, Los Angeles. The proposal is for 3 fellowship slots
in the first year and 4 thereafter to support research programs in years 2 and
3 of a fellowship in Hematology/Oncology. Support is not requested for the
first year's clinical experience, which provides extensive training through
inpatient and outpatient Hematology and Oncology services at the Clinical
Health Sciences Center of UCLA and at affiliated hospitals at the Wadsworth VA
and at the Los Angeles Orthopaedic Hospital. After completion of the first
(clinical) year, the trainee will begin his or her research experience in the
chosen field and with the appropriate faculty mentor. The faculty consists of
21 scientists, about equally divided into 3 research foci, namely,
hematopoiesis and stem cell biology, lymphocytes and host defense and
hemostasis/thrombosis and vascular biology, each research focus of which is
directed by a specialist in that field. All of the mentors have peer-reviewed
Federal funding (20 of 21 with NIH grants), demonstrated success in training
doctoral and/or post-doctoral research fellows, and experience in
collaborative translational projects.
Highest priority for acceptance of fellows into the program will be given to
those whose goals are towards attainment of a PhD degree as part of the
Department of Medicine Specialty Training and Advanced Research (STAR)
Program, to those who already have dual MD/PhD) degrees, and to fellows with
express interest in academic careers and experience in laboratory-oriented
research. Strong efforts will be made to recruit fellows from
underrepresented minority groups, especially through functional interactions
with Drew University of Medicine and Science and the Martin Luther King
Hospital in Los Angeles. Research seminars, work-in-progress sessions, and
scientific retreats will afford special opportunities for selection of future
mentors by fellows and for scientific interchange and project development.
The program offers and independently supports additional research training
beyond year 3 for those trainees who desire further experience to make the
transition to academic investigator. A core curriculum includes required
attendance in the "Clinical Research Course", which covers subjects on
research design and analysis, ethics, regulatory issues, grant preparation and
responsible conduct of research. The progress of fellows towards completion
of their work will be monitored by regular and formal evaluations by the
Steering Committee, which includes 4 PhD's among the 6 members, in concert
with each fellow's mentor. The training of academic hematologists with
expertise in basic, clinical and translational research is an important
priority for academic medical centers and this application seeks support for
the pivotal 2-year period between clinical training and an eventual career in
academic hematology.
描述(由申请人提供):
该应用程序是针对新的(1型)PHS机构国家研究
服务奖为研究员准备血液学学术生涯
加利福尼亚大学洛杉矶。 该提议是针对3个奖学金老虎机
在第一年,此后有4年支持研究计划,以及
血液学/肿瘤学研究金的第3个。 不要求支持
第一年的临床经验,通过
临床的住院和门诊血液学和肿瘤学服务
加州大学洛杉矶分校的健康科学中心和沃兹沃思沃兹沃思的附属医院
并在洛杉矶骨科医院。 完成第一个
(临床)一年,学员将开始他或她的研究经验
选择领域,并与适当的教师导师一起。 教师包括
21个科学家,大约分为3个研究焦点,即
造血和干细胞生物学,淋巴细胞和宿主防御以及
止血/血栓形成和血管生物学,每个研究重点是
由该领域的专家执导。 所有的导师都进行了同行评审
联邦资金(21个NIH赠款中的20个)在培训方面取得了成功
博士学位和/或博士后研究研究员,以及
协作翻译项目。
接受研究员进入该计划的最高优先事项将被授予
那些目标是获得博士学位的人
医学系专业培训和高级研究(Star)
程序,给那些已经拥有双重MD/博士学位的人,并与同伴一起
表达对学术职业和以实验室为导向的经验的兴趣
研究。 将尽力从
代表性不足的少数群体,特别是通过功能互动
与德鲁医学与科学大学和马丁·路德·金
洛杉矶的医院。 研究研讨会,进行工作的会议和
科学务虚会将为选择未来提供特殊的机会
研究员的指导者以及科学交换和项目开发。
该计划提供并独立支持其他研究培训
超过3年级的受训者,他们希望进一步经验
过渡到学术研究员。 核心课程包括所需的
参加“临床研究课程”,该课程涵盖了主题
研究设计和分析,道德,监管问题,授予准备和
负责任的研究。 研究员在完成
他们的工作将通过常规和正式评估来监视
指导委员会,其中包括4名博士学位,共有4位成员
与每个同伴的导师。 通过
基本,临床和转化研究方面的专业知识是重要的
学术医疗中心的优先级,本申请寻求支持
临床培训与最终职业之间的关键2年
学术血液学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
VICTOR JACK MARDER的其他基金
SAFER THROMBOLYTIC THERAPY USING PLASMIN
使用纤溶酶进行更安全的溶栓治疗
- 批准号:67731086773108
- 财政年份:2004
- 资助金额:$ 21.6万$ 21.6万
- 项目类别:
SAFER THROMBOLYTIC THERAPY USING PLASMIN
使用纤溶酶进行更安全的溶栓治疗
- 批准号:72194037219403
- 财政年份:2004
- 资助金额:$ 21.6万$ 21.6万
- 项目类别:
SAFER THROMBOLYTIC THERAPY USING PLASMIN
使用纤溶酶进行更安全的溶栓治疗
- 批准号:70353297035329
- 财政年份:2004
- 资助金额:$ 21.6万$ 21.6万
- 项目类别:
SAFER THROMBOLYTIC THERAPY USING PLASMIN
使用纤溶酶进行更安全的溶栓治疗
- 批准号:68839276883927
- 财政年份:2004
- 资助金额:$ 21.6万$ 21.6万
- 项目类别:
相似国自然基金
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
- 批准号:82371028
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
深度融合人机智能的研究生学术能力评价、归因与提升路径研究
- 批准号:62377008
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
高校预聘制青年教师的学术生态困境及其影响研究
- 批准号:72304027
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
- 批准号:82371145
- 批准年份:2023
- 资助金额:46.00 万元
- 项目类别:面上项目
Monge-Ampère方程和k-Hessian方程解的存在性与边界渐近行为研究
- 批准号:12371112
- 批准年份:2023
- 资助金额:44.00 万元
- 项目类别:面上项目
相似海外基金
Multidisciplinary sickle cell disease obstetrics care program in Ghana: Non-academic vs.Academic Hospital (Pilot Study)
加纳多学科镰状细胞病产科护理计划:非学术医院与学术医院(试点研究)
- 批准号:1073400710734007
- 财政年份:2023
- 资助金额:$ 21.6万$ 21.6万
- 项目类别:
An Intervention to Reduce Cancer Associated Thrombosis Through Improved Prophylaxis
通过改进预防来减少癌症相关血栓形成的干预措施
- 批准号:1072379110723791
- 财政年份:2023
- 资助金额:$ 21.6万$ 21.6万
- 项目类别:
U2C/TL1 NC KUH TRIO Program
U2C/TL1 NC KUH TRIO 计划
- 批准号:1072547010725470
- 财政年份:2023
- 资助金额:$ 21.6万$ 21.6万
- 项目类别:
Control of Telomere Homeostasis by Nucleotide Metabolism in Hematopoiesis
造血过程中核苷酸代谢对端粒稳态的控制
- 批准号:1060617110606171
- 财政年份:2023
- 资助金额:$ 21.6万$ 21.6万
- 项目类别: